Weekly insulin formulations for diabetes

This is a Canada news story, published by Science News, that relates primarily to Efsitora news.

Canada news

For more Canada news, you can click here:

more Canada news

Efsitora news

For more Efsitora news, you can click here:

more Efsitora news

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

Science News news

For more news from Science News, you can click here:

more news from Science News

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

weekly insulin formulations

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest daily insulin shot news, insulin formulations news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

Insulin injections

Science News

•

Once-weekly insulin might mean fewer shots for some with diabetes

Summary

Nutrition label

82% Informative

Two pharmaceutical companies have developed weekly insulin formulations and have tested the drugs in late-stage clinical trials.

Efsitora , from Eli Lilly , and icodec, from Novo Nordisk , have received approval for use in adults with diabetes by the European Union and by Canada and a few other countries.

It will likely take time before things shake out on whether, when and for whom weekly insulin will become available in the United States .

Once-weekly insulin is meant to take the place of a once- daily long-acting shot.

It could make a difference for people’s quality of life “to have to take one less shot a day,” Young says.

People with type 1 diabetes need a system level of fine-tuning on a day-to-day, Romeo says.

VR Score

Informative language

Neutral language

Article tone

informal

Language

English

Language complexity